Fisons ends long hunt for finance director
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.FISONS, the beleaguered pharmaceuticals group, has filled one of its board vacancies with the appointment of David Hankinson as finance director.
Mr Hankinson has the distinction of being one of the shortest- serving finance directors at a large company. He joined Ranks Hovis McDougall, the food group, from Lucas in October 1992 on the same day Hanson launched a pounds 780m bid. RHM was eventually acquired by Tomkins and Mr Hankinson left last March after less than four months in the job.
Fisons has been searching for a finance director since last autumn when Roy Thomas announced his decision to retire. He left at the same time as Cedric Scroggs, dismissed as chief executive after losing the confidence of the board.
A spokeswoman said Fisons had seen a number of candidates to replace Mr Scroggs, 'but so far no one who fits the bill has come forward'. She added that the group had widened its search beyond the pharmaceutical industry to managers from hi-tech sectors.
She said Mr Hankinson was skilled in City relations, which Fisons believes is more important than direct experience of the pharmaceuticals industry.
The departures of Mr Scroggs and Mr Thomas came after a series of disasters for Fisons, starting with the resignation of the previous chairman, John Kerridge, at the beginning of 1992. A series of profit warnings followed and Fisons is expected to reveal next week that it barely broke even in 1993. Its shares were unchanged at 127p.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments